Sign Up Today and Learn More About Algorithm Sciences Stock
Invest in or calculate the value of your shares in Algorithm Sciences or other pre-IPO companies through EquityZen's platform.
Algorithm Sciences Stock (ALSC)
Algorithm Sciences is a biopharmaceutical company that focuses on treatment for rare cardiovascular diseases.
About Algorithm Sciences Stock
Founded
2013
Headquarters
New York, NY, US
Industries
Software, Artificial Intelligence, Financial Services
Algorithm Sciences Press Mentions
Stay in the know about the latest news on Algorithm Sciences
Compositions and methods for vasodilator delivery.
patents • Feb 12, 2025
Algorhythm Holdings, Inc. Announces $2 Million Registered Direct Offering
globenewswire • Dec 17, 2024
Algorhythm Holdings (RIME) Announces Pricing of $9.5 Million Public Offering
streetinsider • Dec 06, 2024
Lucius Partners Portfolio Company Algorithm Sciences, Inc. Closes on the Creation of a Majority Owned Subsidiary - Infusyn Therapeutics
prnewswire • Jun 29, 2024
Lucius Partners Portfolio Company Algorithm Sciences, Inc. Completes the Purchase of Flowonix Assets (Prometra II Pump)
einnews • Jun 27, 2023
Algorithm Sciences Management
Leadership team at Algorithm Sciences
Director
James Ahern
CEO & Founder
Matthew Duffy
Join now and verify your accreditation status to gain access to:
- Algorithm Sciences Current Valuation
- Algorithm Sciences Stock Price
- Algorithm Sciences Management
- Available deals in Algorithm Sciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Algorithm Sciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Algorithm Sciences Revenue and Financials
- Algorithm Sciences Highlights
- Algorithm Sciences Business Model
- Algorithm Sciences Risk Factors
- Algorithm Sciences Research Report from SACRA Research
Trading Algorithm Sciences Stock
How to invest in Algorithm Sciences stock?
Accredited investors can buy pre-IPO stock in companies like Algorithm Sciences through EquityZen funds. These investments are made available by existing Algorithm Sciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Algorithm Sciences stock?
Shareholders can sell their Algorithm Sciences stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
